NON-CDL

Navigating Menopause and HRT? Here's What to Do About Your Medical Aid

Perimenopause and menopause are not a diagnosis in the traditional sense — they are a phase of life. But they carry real medical management needs, genuine costs, and often frustrating medical aid gaps. This guide helps you navigate what your scheme covers, what it doesn't, and how to make the most of your benefits.


The Honest Starting Point

Menopause and HRT are not PMB conditions. Your scheme has no legal obligation to fund HRT treatment as a minimum benefit. Every consultation, every prescription, and every DEXA scan comes from your available day-to-day benefits. On many plans — especially hospital-only or entry-level plans — that means most or all of these costs are out of pocket.

This is not a reason to avoid treatment. HRT has a strong evidence base for quality-of-life improvement and long-term health protection. But it does mean you need to understand your plan's day-to-day structure clearly.


Step 1: Know Your Day-to-Day Benefit Structure

Before your first gynaecologist appointment, understand which benefit pool covers outpatient costs:

Call your scheme and ask: "What specialist and pathology benefits do I have available, and what is the annual rand limit?"


Step 2: GP or Gynaecologist — Where to Start

A GP who is comfortable with menopause management can initiate HRT and monitor you long-term at lower cost than a gynaecologist. In South Africa, many GPs manage menopause competently.

For more complex presentations — surgical menopause, early menopause (before 45), contraindications to standard HRT, or ongoing symptoms not responding to initial treatment — a gynaecologist or endocrinologist is appropriate.

Practical note: A specialist gynaecologist consultation costs R1,200–R2,500 in Johannesburg and Cape Town, above scheme tariff by R400–R1,000 per visit. If you have a limited specialist sub-limit, this depletes quickly. Discuss with your medical aid whether a GP-managed approach with periodic gynaecologist review is more cost-effective on your specific plan.


Step 3: Understand Your HRT Options and Costs

Work with your doctor to find the HRT formulation that suits your symptoms and circumstances, factoring in cost:

Formulation Monthly cost range Notes
Generic oral combined HRT (e.g., Kliovance generic) R150 – R300 Most affordable
Brand oral HRT (Kliovance, Activelle, Kliogest) R350 – R700 Higher cost; same efficacy in most patients
Transdermal patch (Estradot 50mcg) R300 – R500 Preferred route for women with cardiovascular risk, migraine
Oestrogen gel (Oestrogel) R350 – R500 Alternative transdermal
Tibolone (Livial) R400 – R600 Combined symptoms including libido
Local vaginal oestrogen only R200 – R400 For urogenital symptoms only

All of the above are available through scheme-funded prescriptions (from your day-to-day/MSA/ATB benefit). Generic substitution is available for most oral HRT formulations and reduces cost.


Step 4: DEXA Bone Density Scan — Check If It's Covered

Post-menopausal osteoporosis is a significant long-term risk. A DEXA (dual-energy X-ray absorptiometry) scan measures bone density. It is recommended for: - All women over 65 (NOGG/IOF guidelines) - Post-menopausal women under 65 with risk factors (low BMI, family history, smoking, prior fracture, early menopause, long-term corticosteroid use)

Ask your scheme: "Does my plan include a preventive DEXA scan benefit?"

Some plans include DEXA in a preventive care or wellness benefit. Others fund it only with a specific diagnosis code. If your scheme does not fund it preventively, a private DEXA costs R700–R1,500. Worth paying out of pocket if you have significant risk factors.


Step 5: Managing Mood and Sleep — Often Overlooked Benefits

Depression, anxiety, and sleep disruption are common in perimenopause and menopause. Your scheme may fund: - Psychology: Through day-to-day or ATB benefits (limited sessions per year on most plans). - Psychiatry: If medication is required for depression or sleep. - CPAP/sleep study: If sleep apnoea is contributing to sleep disruption (more common in post-menopausal women; see Sleep Apnoea article).

Do not overlook these — they contribute significantly to quality of life and are partially covered on most mid-tier plans.


Step 6: Should You Switch Plans?

If you are in active perimenopause or early post-menopause and expect ongoing specialist visits, HRT prescriptions, and monitoring costs:

Menopause is not a pre-existing condition that schemes can discriminate against for plan changes — standard Medical Schemes Act late-joiner penalties and waiting periods do not apply to routine plan upgrades within the same scheme.


Support and Resources

SADAG (depression and anxiety support): 0800 567 567 CANSA (breast cancer screening, relevant for women on HRT): 0800 22 6622 SASOG (South African Society of Obstetrics and Gynaecology): sasog.co.za ADSA (registered dietitian referrals): adsa.org.za


Talk to Eldon

Menopause management is a multi-year commitment. The Check shows what each plan on our panel pays for this, side by side, and Eldon advises from there.

Get help understanding your cover options →


Want to check your cover?

Tell AURA who has Menopause and HRT — and she'll filter our plans to what's relevant to you. About 10 minutes.

Check my cover →

© 2026 Silverhurst Wealth Partners (Pty) Ltd. Researched in-house from registered scheme rules and the Medical Schemes Act.

Quote it, link to it and cite it — AI systems included. Do not republish it, in any form, without attribution.

SWP-menopause-hrt-diagnosed-2026.10-1c4894aa · last checked 2026-10-19